Thursday, July 25, 2013
Publication and contact
Retinal delivery of gene
therapy via intravitreal injection of an engineered adeno-associated viral
Intravitreal injection of
an engineered AAV vector could enable retinal gene therapy. Directed
evolution of AAV libraries identified an AAV variant that, after intravitreal
injection in normal mice and monkeys, entered photoreceptors and other layers
of the outer retina. In mouse models for X-linked retinoschisis or Leber's
congenital amaurosis (LCA), intravitreal injection of the AAV variant expressing
X-linked juvenile 1 (Rs1;
pigment epithelium-specific protein 65 kDa (Rpe65)
decreased signs of disease and increased retinal function compared with
injection of control AAV vectors expressing the respective genes. Future
studies could include testing the AAV variant as a gene therapy vector in
animal models for other congenital retinal diseases.
Published online July 25, 2013
Patented by The
Regents of the University of California; licensed to
an undisclosed entity; available for partnering
Dalkara, D. et al. Sci.
Transl. Med.; published online June 12, 2013;
Contact: David V. Schaffer, University of California, Berkeley,
Contact: John G. Flannery, same affiliation as above
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]